Brief: Galapagos To Wind Down Its Cell Therapy Business

Lakefront Biotherapeutics NV

21/10/2025 06:34

Oct 21 (Reuters) - Galapagos NV GLPG.AS:

GALAPAGOS ANNOUNCES INTENTION TO WIND DOWN CELL THERAPY BUSINESS AS PART OF THE COMPANY’S ONGOING TRANSFORMATION

WIND DOWN TO IMPACT 365 EMPLOYEES GLOBALLY

CLOSURE OF SITES IN NETHERLANDS, SWITZERLAND, U.S., AND CHINA

EXPECT €100-€125 MILLION OPERATING COSTS, €150-€200 MILLION RESTRUCTURING COSTS

WIND DOWN APPROVED BY GALAPAGOS BOARD, EXCLUDING GILEAD DIRECTORS

UPDATED 2025 CASH OUTLOOK WILL BE PROVIDED WITH COMPANY'S THIRD-QUARTER EARNINGS IN EARLY NOVEMBER

Source text: ID:nGNX9cJbY0

Further company coverage: GLPG.AS

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))